-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Assumes Tyra Biosciences at Buy, Announces Price Target of $55

Benzinga·11/20/2026 13:39:07
Diffusion vocale
Guggenheim analyst Debjit Chattopadhyay assumes Tyra Biosciences (NASDAQ:TYRA) with a Buy rating and announces Price Target of $55.